EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 299 filers reported holding EXELIXIS INC in Q1 2018. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $212,360 | -1.1% | 8,949 | 0.0% | 0.00% | 0.0% |
Q4 2023 | $214,687 | +7.9% | 8,949 | -29.5% | 0.00% | 0.0% |
Q3 2022 | $199,000 | -24.6% | 12,693 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $264,000 | -14.6% | 12,693 | -6.8% | 0.00% | 0.0% |
Q1 2022 | $309,000 | +24.1% | 13,622 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $249,000 | -7.8% | 13,622 | +6.7% | 0.00% | 0.0% |
Q3 2021 | $270,000 | +28.0% | 12,763 | +10.4% | 0.00% | 0.0% |
Q2 2021 | $211,000 | -19.2% | 11,559 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $261,000 | +11.5% | 11,559 | -0.9% | 0.00% | 0.0% |
Q4 2020 | $234,000 | -17.9% | 11,661 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $285,000 | +5.6% | 11,661 | +2.5% | 0.00% | -50.0% |
Q2 2020 | $270,000 | +37.8% | 11,372 | 0.0% | 0.00% | +100.0% |
Q1 2020 | $196,000 | -2.0% | 11,372 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $200,000 | +7.0% | 11,372 | +7.6% | 0.00% | 0.0% |
Q3 2019 | $187,000 | -17.3% | 10,572 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $226,000 | -10.3% | 10,572 | 0.0% | 0.00% | -50.0% |
Q1 2019 | $252,000 | +21.2% | 10,572 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $208,000 | +11.2% | 10,572 | 0.0% | 0.00% | +100.0% |
Q3 2018 | $187,000 | -18.0% | 10,572 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $228,000 | +4.6% | 10,572 | +7.4% | 0.00% | 0.0% |
Q1 2018 | $218,000 | -27.1% | 9,840 | 0.0% | 0.00% | -50.0% |
Q4 2017 | $299,000 | +25.6% | 9,840 | 0.0% | 0.00% | +100.0% |
Q3 2017 | $238,000 | – | 9,840 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 15,001,073 | $320,572,000 | 64.48% |
Sargent Investment Group, LLC | 432,125 | $9,235,000 | 4.22% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 443,534 | $9,483,000 | 3.52% |
Bellevue Group AG | 3,878,800 | $82,890,000 | 1.42% |
CAPITAL MANAGEMENT CORP /VA | 237,855 | $5,083,000 | 1.40% |
Orbimed Advisors | 3,912,900 | $83,619,000 | 1.30% |
Portolan Capital Management | 540,590 | $11,552,000 | 1.24% |
TEALWOOD ASSET MANAGEMENT INC | 139,347 | $2,978,000 | 1.21% |
Signition LP | 84,120 | $1,798,000,000 | 1.18% |
Penn Capital Management Company, LLC | 529,630 | $11,318,000 | 1.12% |